ICD-10 checklists—A tool for clinicians' use of the ICD-10 classification of mental and behavioral disorders

1996 ◽  
Vol 37 (3) ◽  
pp. 180-187 ◽  
Author(s):  
A Janca ◽  
W Hiller
Keyword(s):  
Behavioral Disorders ◽  
Icd 10 ◽  
Mental And Behavioral Disorders

Opioid use disorders national registries and opioids sales registries: A 10-year prevalence study from a middle-income country

2021 ◽  
Vol 17 (5) ◽  
pp. 383-388
Author(s):  
Daniela Yucumá, MD ◽  
Ana Beatriz Pizarro, RN ◽  
Diego Alberto Moreno, MD ◽  
Juan David Mosos, MD ◽  
Marian Rincón-Montaña, MD ◽  
...  
Keyword(s):  
Behavioral Disorders ◽  
Progressive Increase ◽  
National Registry ◽  
Middle Income Country ◽  
Opioid Use ◽  
Middle Income ◽  
Middle Income Countries ◽  
Icd 10 ◽  
Opioid Use Disorders ◽  
Mental And Behavioral Disorders

Objectives: (1) To estimate the prevalence, geographic distribution, and demographic characteristics of patients diagnosed with mental and behavioral disorders due to the use of opioids in Colombia, between 2009 and 2018. (2) To describe the opioid sales trends in Colombia over the last few years.Methods: We conducted an observational study analyzing information from Individual National Registry of Health Services and the Colombian official database for pharmaceuticals prices and quantities sold. The included ICD-10 codes were mental and behavioral disorders due to the use of opioids (F11) codes subdivisions.Results: 12,557 cases of mental and behavioral disorders due to opioid use were reported, with a rate of 3.0 per 100,000 inhabitants for the studied period. Men represented 74.2 percent, with a male:female ratio of 2.9:1. The highest prevalence was found between 20 and 24 years, in the northwest Colombian area. A progressive increase in the total number of opioid units sold during the study period was found, and the most frequently sold opioids were tramadol (55 percent) and codeine (20 percent).Conclusions: Recognition of opioid use disorders has increased in the last 10 years; it affects more males than females, mostly young adults, and is higher in certain affluent regions of Colombia. We found a progressive annual increase in the sales of opioids in the country, which could be related to the increase in the rate of registries. Studies that have analyzed opioid abuse in Latin America are limited, and further studies are needed to evaluate this situation in middle-income countries from the region.

scholarly journals Comorbidities of mental and behavioral disorders in chemically dependent patients in different periods of abstinence

2012 ◽  
Vol 61 (3) ◽  
pp. 139-147 ◽  
Author(s):  
Maria de Lourdes Pereira Costa ◽  
Luiz Carlos Marques de Oliveira
Keyword(s):  
Behavioral Disorders ◽  
Psychotic Disorders ◽  
Psychosocial Care ◽  
Response To Treatment ◽  
Additional Information ◽  
Icd 10 ◽  
Group 3 ◽  
Group 2 ◽  
Mental And Behavioral Disorders ◽  
Group 1

OBJECTIVE: To assess the frequency of comorbidities of mental and behavioral disorders (CMBD) in psychoactive substance (PAS)-dependent patients with different periods of abstinence cared for at Alcohol and Other Drug Psychosocial Care Centers (CAPS-ad). METHOD: All patients under treatment in the two CAPS-ad of the city of Uberlândia-MG, between April and September 2010, were consecutively assessed. The ICD-10 symptom checklist was used to diagnose CMBD; additional information was obtained from interviews and medical records. The patients were divided according to duration of abstinence: < 1 week (Group 1); 1-4 weeks (Group 2); and > 4 weeks (Group 3). RESULTS: Of all patients assessed, 62.8% were diagnosed with CMBD, which were more frequent (p < 0.05) in Group 1 (72%) than Group 3 (54.2%), and both groups were similar to Group 2 (61%). Depressive and anxiety disorders were more frequent among patients of Group 1. Mood disorders were more frequent (p < 0.05) in women [22/34 (65%) vs. 54/154 (35.1%)], whereas psychotic disorders were more frequent (p = 0.05) in men [16/154 (10.4%) vs. 0]. The presence of CMBD was associated with more severe clinical conditions. CONCLUSIONS: The higher frequency of diagnosis of CMBD in patients of Group 1 may have resulted from the difficulties in distinguishing mental disorders that are due to PAS intoxication or withdrawal from those that are not. However, to make the diagnosis of CMBD, even during detoxification, can increase the likelihood of better response to treatment.

Sign in / Sign up

Export Citation Format

Share Document